Youre paying AED 744 to AED 2,000+ per month out of pocket for the drug alone
Desvergne, B., Petty, K
Tirzepatide is FDA-approved for weight loss under the brand name Zepbound and is available in Canada through Mounjaro (approved for type 2 diabetes) with growing off-label weight management use
If applicable, progress to Section B for Chronic Idiopathic Urticaria (CIU), answering diagnostic questions regarding symptomatology and previous treatments
Most human observational and intervention evidence for the effects of these drugs has been derived from populations with type 2 diabetes mellitus, and there is a need for intervention studies for older people with, and at risk of, sarcopenia to further investigate the balance of benefit and risk in these target populations
[1] [4] Common adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, constipation, and abdominal discomfort, which are typically most pronounced during dose escalation